Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts. Annu Rev Immunol 2011; 30:677 706; PMID: 22224761
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11:723 - 37; http://dx.doi.org/10.1038/nri3073; PMID: 21997792
   PubMed Web of Science ®Google Scholar
• Sonnemann KJ, Bement WM. Wound repair: toward understanding and integration of single-cell and multicellular wound responses. Annu Rev Cell Dev Biol 2011; 27:237 - 63; http://dx.doi.org/10.1146/annurev-cellbio-092910-154251; PMID: 21721944
   PubMed Web of Science ®Google Scholar
• Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7:211 - 7; http://dx.doi.org/10.1016/j.ccr.2005.02.013; PMID: 15766659
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 2011; 331:1565 - 70; http://dx.doi.org/10.1126/science.1203486; PMID: 21436444
   PubMed Web of Science ®Google Scholar
• Qazi BS, Tang K, Qazi A. Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam 2011; 908468
   PubMedGoogle Scholar
• Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33 - 45; http://dx.doi.org/10.1016/j.cell.2007.08.017; PMID: 17923086
   PubMed Web of Science ®Google Scholar
• Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS, et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 2009; 16:208 - 19; http://dx.doi.org/10.1016/j.ccr.2009.07.015; PMID: 19732721
   PubMed Web of Science ®Google Scholar
• Kuo SH, Yeh KH, Wu MS, Lin CW, Hsu PN, Wang HP, et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood 2012; 119:4838 - 44; http://dx.doi.org/10.1182/blood-2012-01-404194; PMID: 22403257
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356:2131 - 42; http://dx.doi.org/10.1056/NEJMoa067208; PMID: 17522398
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 2009; 302:649 - 58; http://dx.doi.org/10.1001/jama.2009.1112; PMID: 19671906
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10:181 - 93; http://dx.doi.org/10.1038/nrc2809; PMID: 20168319
   PubMed Web of Science ®Google Scholar
• Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87:803 - 9; http://dx.doi.org/10.1016/S0092-8674(00)81988-1; PMID: 8945508
   PubMed Web of Science ®Google Scholar
• Tedesco D, Haragsim L.. Cyclosporine: a review. J Transplant 2012; 2012:230386
   PubMedGoogle Scholar
• Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472 - 84; http://dx.doi.org/10.1038/nri1632; PMID: 15928679
   PubMed Web of Science ®Google Scholar
• Müller MR, Rao A. NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 2010; 10:645 - 56; http://dx.doi.org/10.1038/nri2818; PMID: 20725108
   PubMed Web of Science ®Google Scholar
• Mancini M, Toker A. NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009; 9:810 - 20; http://dx.doi.org/10.1038/nrc2735; PMID: 19851316
   PubMed Web of Science ®Google Scholar
• Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 2008; 28:7168 - 81; http://dx.doi.org/10.1128/MCB.00256-08; PMID: 18809576
   PubMed Web of Science ®Google Scholar
• Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997; 275:1930 - 4; http://dx.doi.org/10.1126/science.275.5308.1930; PMID: 9072970
   PubMed Web of Science ®Google Scholar
• Yang TT, Yu RY, Agadir A, Gao GJ, Campos-Gonzalez R, Tournier C, et al. Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4. Mol Cell Biol 2008; 28:3489 - 501; http://dx.doi.org/10.1128/MCB.01847-07; PMID: 18347059
   PubMed Web of Science ®Google Scholar
• Araki K, Ellebedy AH, Ahmed R. TOR in the immune system. Curr Opin Cell Biol 2011; 23:707 - 15; http://dx.doi.org/10.1016/j.ceb.2011.08.006; PMID: 21925855
   PubMed Web of Science ®Google Scholar
• Powell JD, Delgoffe GM. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010; 33:301 - 11; http://dx.doi.org/10.1016/j.immuni.2010.09.002; PMID: 20870173
   PubMed Web of Science ®Google Scholar
• Iñiguez MA, Martinez-Martinez S, Punzón C, Redondo JM, Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 2000; 275:23627 - 35; http://dx.doi.org/10.1074/jbc.M001381200; PMID: 10816557
   PubMed Web of Science ®Google Scholar
• Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9:550 - 62; http://dx.doi.org/10.1038/nrc2664; PMID: 19629070
   PubMed Web of Science ®Google Scholar
• Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009; 8:627 - 44; http://dx.doi.org/10.1038/nrd2926; PMID: 19644473
   PubMed Web of Science ®Google Scholar
• Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004; 4:335 - 48; http://dx.doi.org/10.1038/nrc1362; PMID: 15122205
   PubMed Web of Science ®Google Scholar
• Fernandez-Zapico ME, Ellenrieder V. NFAT transcription factors, the potion mediating “Dr. Jekill-Mr. Hyde” transformation of the TGFβ pathway in cancer cells. Cell Cycle 2010; 9:3838 - 9; http://dx.doi.org/10.4161/cc.9.19.13413; PMID: 20935481
   PubMed Web of Science ®Google Scholar
• Gooch JL, Gorin Y, Zhang BX, Abboud HE. Involvement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular matrix accumulation. J Biol Chem 2004; 279:15561 - 70; http://dx.doi.org/10.1074/jbc.M308759200; PMID: 14742441
   PubMed Web of Science ®Google Scholar
• Singh G, Singh SK, König A, Reutlinger K, Nye MD, Adhikary T, et al. Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation. J Biol Chem 2010; 285:27241 - 50; http://dx.doi.org/10.1074/jbc.M110.100438; PMID: 20516082
   PubMed Web of Science ®Google Scholar
• Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, et al. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991; 174:1259 - 62; http://dx.doi.org/10.1084/jem.174.5.1259; PMID: 1682412
   PubMed Web of Science ®Google Scholar
• Minguillón J, Morancho B, Kim SJ, López-Botet M, Aramburu J. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. J Leukoc Biol 2005; 77:748 - 58; http://dx.doi.org/10.1189/jlb.0904503; PMID: 15716327
   PubMed Web of Science ®Google Scholar
• Prashar Y, Khanna A, Sehajpal P, Sharma VK, Suthanthiran M. Stimulation of transforming growth factor-beta 1 transcription by cyclosporine. FEBS Lett 1995; 358:109 - 12; http://dx.doi.org/10.1016/0014-5793(94)01382-B; PMID: 7828718
   PubMed Web of Science ®Google Scholar
• Stover DG, Bierie B, Moses HL. A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 2007; 101:851 - 61; http://dx.doi.org/10.1002/jcb.21149; PMID: 17486574
   PubMed Web of Science ®Google Scholar
• Akool S, Doller A, Babelova A, Tsalastra W, Moreth K, Schaefer L, et al. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J Immunol 2008; 181:2831 - 45; PMID: 18684975
   PubMed Web of Science ®Google Scholar
• Azzolin L, von Stockum S, Basso E, Petronilli V, Forte MA, Bernardi P. The mitochondrial permeability transition from yeast to mammals. FEBS Lett 2010; 584:2504 - 9; http://dx.doi.org/10.1016/j.febslet.2010.04.023; PMID: 20398660
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11:700 - 14; http://dx.doi.org/10.1038/nrm2970; PMID: 20823910
   PubMed Web of Science ®Google Scholar
• Aramburu J, Garcia-Cózar F, Raghavan A, Okamura H, Rao A, Hogan PG. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell 1998; 1:627 - 37; http://dx.doi.org/10.1016/S1097-2765(00)80063-5; PMID: 9660947
   PubMed Web of Science ®Google Scholar
• Kaibori M, Sakitani K, Oda M, Kamiyama Y, Masu Y, Nishizawa M, et al. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol 1999; 30:1138 - 45; http://dx.doi.org/10.1016/S0168-8278(99)80270-0; PMID: 10406194
   PubMed Web of Science ®Google Scholar
• Perkins ND. The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 2012; 12:121 - 32; PMID: 22257950
   PubMed Web of Science ®Google Scholar
• Yang G, Xiao X, Rosen DG, Cheng X, Wu X, Chang B, et al. The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer. Clin Cancer Res 2011; 17:2181 - 94; http://dx.doi.org/10.1158/1078-0432.CCR-10-3265; PMID: 21339307
   PubMed Web of Science ®Google Scholar
• Corral RS, Iñiguez MA, Duque J, López-Pérez R, Fresno M. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene 2007; 26:958 - 69; http://dx.doi.org/10.1038/sj.onc.1209856; PMID: 16909108
   PubMed Web of Science ®Google Scholar
• Masuo T, Okamura S, Zhang Y, Mori M. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen. Cancer Lett 2009; 285:66 - 72; http://dx.doi.org/10.1016/j.canlet.2009.05.001; PMID: 19481339
   PubMed Web of Science ®Google Scholar
• Basu A, Banerjee P, Contreras AG, Flynn E, Pal S. Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40. PLoS One 2011; 6:e23919; http://dx.doi.org/10.1371/journal.pone.0023919; PMID: 21886838
   PubMedGoogle Scholar
• Basu A, Banerjee P, Pal S. Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression. Cell Cycle 2012; 11:633 - 4; http://dx.doi.org/10.4161/cc.11.4.19276; PMID: 22293493
   PubMed Web of Science ®Google Scholar
• Piao SG, Bae SK, Lim SW, Song JH, Chung BH, Choi BS, et al. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction. Transplantation 2012; 93:383 - 9; http://dx.doi.org/10.1097/TP.0b013e3182421604; PMID: 22267156
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140:1807 - 16; http://dx.doi.org/10.1053/j.gastro.2011.01.057; PMID: 21530747
   PubMed Web of Science ®Google Scholar
• Loh C, Shaw KT, Carew J, Viola JP, Luo C, Perrino BA, et al. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 1996; 271:10884 - 91; http://dx.doi.org/10.1074/jbc.271.18.10884; PMID: 8631904
   PubMed Web of Science ®Google Scholar